🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
31Score
DipBuster Score™
$94.17
+$1.07 (+1.15%)
Live price · Source: Yahoo
52-Week Position
$73.31
63% of range
$106.33
Beta
0.574
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.574
52W High$106.33
52W Low$73.31
DipBuster Brief
Key signals at a glance
Zone: Hold / Watch
Neutral
Mid-Range Position (63% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position63% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.574
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Medtronic plc (MDT), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-08-20 | Marinaro Michael | SELL | 1,084 |
| 2026-08-03 | Thompson Kweli | BUY | 49,167 |
| 2026-08-03 | Thompson Kweli | BUY | 17,306 |
| 2026-08-03 | Thompson Kweli | BUY | 6,923 |
| 2026-08-03 | Blomquist Denise L. | BUY | 1,366 |
| 2026-08-03 | Blomquist Denise L. | BUY | 2,337 |
| 2026-08-03 | Blomquist Denise L. | BUY | 2,337 |
| 2026-08-03 | Pieton Thierry | BUY | 81,945 |
| 2026-08-03 | Pieton Thierry | BUY | 28,842 |
| 2026-08-03 | Pieton Thierry | BUY | 11,537 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.574
Dividend/yrNone
52W High$106.33
52W Low$73.31
52-Week Range
$73.31Now$106.33
63% through annual range
From 52W High−11.4%
From 52W Low+28.5%
📖 Plain English Summary
Medtronic plc is at 63% of its 52-week range. Beta 0.574 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for MDT
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — MDT
Heuristic · balance sheet, insider filings, price data, academic research
Medtronic plc — DipBuster Score 31/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Medtronic plc free
Add MDT to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
15/25
Momentum & Volume
11/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
7
/100 · NEUTRAL
dip depth
7/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
⚪
Not a Dip
DipBuster Score: 31/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinic…
Sector
Healthcare
Market
🇺🇸 US
CEO
Geoffrey Straub Martha
Staff
95,000 employees
Website